Item 8.01. Other Events.

On April 1, 2020, the U.S. Federal Trade Commission (the "FTC") issued an Administrative Complaint In the Matter of Altria Group, Inc. and JUUL Labs, Inc., Docket No. 9393 (the "Complaint"). The Complaint alleges that Altria Group, Inc. ("Altria") and JUUL Labs, Inc. ("JUUL") entered into a series of agreements, including Altria's acquisition of a 35% interest in JUUL (the "Transaction"), that eliminated competition in violation of Section 1 of the Sherman Act, Section 5 of the Federal Trade Commission Act and Section 7 of the Clayton Act. If the FTC prevails on the Complaint, the FTC may order various forms of relief, including divestiture of Altria's equity stake in JUUL and/or rescission of Altria's purchase of that stake, the voiding of all agreements between Altria and JUUL related to the Transaction and a prohibition against any director or officer of either Altria or JUUL serving on the other party's board of directors or attending meetings of its board of directors.

The FTC has not sought to preliminarily enjoin Altria from converting its non-voting JUUL shares to voting shares, and Altria is currently considering whether to do so.

On April 1, 2020, Altria issued a press release regarding the Complaint. A copy of the press release is attached as Exhibit 99.1 and incorporated into this Form 8-K by reference.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits

       99.1        Altria Group, Inc. Press Release, dated April 1, 2020
        104      The cover page from this Current Report on Form 8-K, formatted in
                 Inline XBRL (included as Exhibit 101)




                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses